4AA-32536-41723
2 vaccinations
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 620 / IL
- Registered
- 2021-06-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-11
Dose 1 — Pfizer-BioNTech
-
2021-06-24
Registered in v-safe
- 2021-06-25
- 2021-07-02
-
2021-07-06
Dose 2 — Pfizer-BioNTech
-
2021-07-10
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
- 2021-07-11
- 2021-07-12
-
2021-07-13
Survey response — day 7, dose 2MedDRA: Mastitis — Feeling: GoodFree text: Diagnosed with mastitis in left breast three days after receiving vaccine in left arm.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-20
- 2021-07-27
- 2021-08-03
- 2021-08-10
- 2021-08-17
- 2021-10-05
- 2022-01-04
- 2022-07-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-11 | Pfizer-BioNTech | No |
| 2 | 2021-07-06 | Pfizer-BioNTech | No |
Free text
Release 9 — day 7, dose 2
Systemic reaction (other): Diagnosed with mastitis in left breast three days after receiving vaccine in left arm.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Mastitis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release